This pilot study assessed the impact of a 1-time motivationally based psychoeducational tobacco cessation intervention during substance use disorder treatment on use of subsequent smoking cessation services.
Participants were 89 veterans in substance use disorder treatment who attended the smoking cessation orientation group. Participants took part in a multimedia psychoeducational group designed to provide veterans education about and motivation to seek subsequent tobacco cessation services. Measures included a self-report survey of demographics, substance use, mental health, tobacco use and cessation, and attendance to tobacco cessation services.
Results indicated that 86.5% of participants used tobacco and on average were heavily nicotine dependent. Fifty-seven percent of tobacco users used follow-up cessation services. Logistic regression indicated that utilization of cessation services was associated with desiring to quit smoking for health purposes and personal choice, history of psychotic disorder, and previous use of nicotine replacement.
A 1-time intervention with veterans in substance use disorder treatment can increase motivation to seek subsequent tobacco cessation services, providing an avenue for reducing tobacco use in this population.
*Department of Psychology, The University of Texas at El Paso, El Paso, TX
†Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, MD
‡Addictive Disorders Treatment Program, G. V. (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, MS
This project was funded by the South Central Mental Illness Research, Education, and Clinical Center (MIRECC) Clinical Education Grants Program.
Reprints: Theodore V. Cooper, PhD, Department of Psychology, University of Texas at El Paso, 500 W. University Avenue, El Paso, TX 79968 (e-mail: email@example.com).
MIRECCs are congressionally established centers designed to investigate the causes of mental illness, develop new treatments for mental illness, and evaluate both established and new treatments with the goal of identifying best practices.